DE60325770D1 - Verwendung von rimexolon zur behandlung von augentrockenheit - Google Patents
Verwendung von rimexolon zur behandlung von augentrockenheitInfo
- Publication number
- DE60325770D1 DE60325770D1 DE60325770T DE60325770T DE60325770D1 DE 60325770 D1 DE60325770 D1 DE 60325770D1 DE 60325770 T DE60325770 T DE 60325770T DE 60325770 T DE60325770 T DE 60325770T DE 60325770 D1 DE60325770 D1 DE 60325770D1
- Authority
- DE
- Germany
- Prior art keywords
- rimexolone
- treatment
- eye dryness
- dryness
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010013774 Dry eye Diseases 0.000 title 1
- QTTRZHGPGKRAFB-OOKHYKNYSA-N rimexolone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CC)(C)[C@@]1(C)C[C@@H]2O QTTRZHGPGKRAFB-OOKHYKNYSA-N 0.000 title 1
- 229960001487 rimexolone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43625502P | 2002-12-24 | 2002-12-24 | |
| PCT/US2003/040374 WO2004058273A1 (en) | 2002-12-24 | 2003-12-18 | Use of rimexolone in the treatment of dry eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60325770D1 true DE60325770D1 (de) | 2009-02-26 |
Family
ID=32682365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60325770T Expired - Lifetime DE60325770D1 (de) | 2002-12-24 | 2003-12-18 | Verwendung von rimexolon zur behandlung von augentrockenheit |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US20040132704A1 (de) |
| EP (1) | EP1575597B1 (de) |
| JP (1) | JP2006513213A (de) |
| KR (2) | KR100889170B1 (de) |
| CN (1) | CN100388919C (de) |
| AR (1) | AR042790A1 (de) |
| AT (1) | ATE419856T1 (de) |
| AU (1) | AU2003299696B2 (de) |
| BR (1) | BR0317774A (de) |
| CA (1) | CA2507375C (de) |
| CY (1) | CY1108862T1 (de) |
| DE (1) | DE60325770D1 (de) |
| DK (1) | DK1575597T3 (de) |
| ES (1) | ES2316867T3 (de) |
| HK (1) | HK1076248A1 (de) |
| MX (1) | MXPA05006985A (de) |
| PL (1) | PL378877A1 (de) |
| PT (1) | PT1575597E (de) |
| RU (1) | RU2330668C2 (de) |
| SI (1) | SI1575597T1 (de) |
| TW (1) | TWI335819B (de) |
| UY (1) | UY28126A1 (de) |
| WO (1) | WO2004058273A1 (de) |
| ZA (1) | ZA200503975B (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
| US7779039B2 (en) | 2004-04-02 | 2010-08-17 | Salesforce.Com, Inc. | Custom entities and fields in a multi-tenant database system |
| WO2006031848A2 (en) * | 2004-09-15 | 2006-03-23 | Ivax Corporation | Corticosteroid topical dispersion with low content of surfactant |
| CN101258483B (zh) | 2005-09-09 | 2015-08-12 | 易享信息技术（上海）有限公司 | 用于在多租户数据库环境中导出、发布、浏览和安装随需应用的系统及其方法 |
| PT3184526T (pt) | 2005-12-13 | 2018-12-19 | Incyte Holdings Corp | Derivados de pirrolo[2,3-d]pirimidina como inibidores da cinase janus |
| US8138156B2 (en) * | 2006-10-18 | 2012-03-20 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
| US20080312259A1 (en) | 2007-06-13 | 2008-12-18 | Incyte Corporation | SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| US8629099B2 (en) * | 2008-03-25 | 2014-01-14 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising a dipeptide |
| CL2009001884A1 (es) * | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
| US20100087550A1 (en) * | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
| ES2487542T3 (es) * | 2009-05-22 | 2014-08-21 | Incyte Corporation | Derivados de N-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de cinasas Janus |
| CN106967070A (zh) | 2009-05-22 | 2017-07-21 | 因塞特控股公司 | 作为jak抑制剂的化合物 |
| AU2010256652B2 (en) * | 2009-06-05 | 2015-11-26 | Allergan, Inc. | Artificial tears and therapeutic uses |
| AR078012A1 (es) * | 2009-09-01 | 2011-10-05 | Incyte Corp | Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus |
| TWI766281B (zh) | 2010-03-10 | 2022-06-01 | 美商英塞特控股公司 | 作為jak1抑制劑之哌啶-4-基三亞甲亞胺衍生物 |
| PE20130216A1 (es) | 2010-05-21 | 2013-02-27 | Incyte Corp | Formulacion topica para un inhibidor de jak |
| AR083933A1 (es) | 2010-11-19 | 2013-04-10 | Incyte Corp | Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak |
| JP5917544B2 (ja) | 2010-11-19 | 2016-05-18 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｊａｋ阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン |
| EA201490042A1 (ru) | 2011-06-20 | 2014-10-30 | Инсайт Корпорейшн | Азетидинил-фенил-, пиридил- или пиразинилкарбоксамидные производные как ингибиторы jak |
| TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| US8324171B1 (en) | 2012-02-06 | 2012-12-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
| US8664180B2 (en) | 2012-02-06 | 2014-03-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
| US9549966B2 (en) | 2012-02-21 | 2017-01-24 | Massachusetts Eye & Ear Infirmary | Inflammatory eye disorders |
| AR091079A1 (es) | 2012-05-18 | 2014-12-30 | Incyte Corp | Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak |
| SG11201503695XA (en) | 2012-11-15 | 2015-06-29 | Incyte Corp | Sustained-release dosage forms of ruxolitinib |
| HUE057262T2 (hu) | 2013-03-06 | 2022-04-28 | Incyte Holdings Corp | Eljárás és köztitermékek JAK inhibitor elõállítására |
| US9655854B2 (en) | 2013-08-07 | 2017-05-23 | Incyte Corporation | Sustained release dosage forms for a JAK1 inhibitor |
| RU2559580C1 (ru) * | 2014-03-18 | 2015-08-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПбГПМУ Минздрава России) | Препарат для лечения синдрома "сухого глаза" |
| US9498467B2 (en) | 2014-05-30 | 2016-11-22 | Incyte Corporation | Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1 |
| CN106420797A (zh) * | 2016-12-06 | 2017-02-22 | 郑州郑先医药科技有限公司 | 一种治疗干眼病的西药组合及其制备方法 |
| CN106581035A (zh) * | 2016-12-06 | 2017-04-26 | 郑州郑先医药科技有限公司 | 一种治疗干眼病的西药组合物 |
| AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
| CN112105608B (zh) | 2018-01-30 | 2023-07-14 | 因赛特公司 | 制备(1-(3-氟-2-(三氟甲基)异烟碱基)哌啶-4-酮)的方法 |
| AU2019245420A1 (en) | 2018-03-30 | 2020-11-12 | Incyte Corporation | Treatment of hidradenitis suppurativa using JAK inhibitors |
| KR102269835B1 (ko) | 2019-10-08 | 2021-06-29 | 한국전력공사 | 펜형 케이블 식별장치 및 케이블 식별 시스템 |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
| US20240166971A1 (en) * | 2022-10-26 | 2024-05-23 | Bausch + Lomb Ireland Limited | Contact lens treating solution |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4686214A (en) * | 1985-10-30 | 1987-08-11 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| JPS63203620A (ja) * | 1985-10-30 | 1988-08-23 | アルコン ラボラトリ−ズ インコ−ポレイテツド | 眼科用の抗炎症性組成物 |
| US5360611A (en) * | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
| US5461081A (en) * | 1989-09-28 | 1995-10-24 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| USRE34578E (en) * | 1990-05-07 | 1994-04-05 | Lubkin; Virginia | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| US5460834A (en) * | 1991-12-13 | 1995-10-24 | Alcon Laboratories, Inc. | Combinations of polymers for use in physiological tear compositions |
| WO1993017664A1 (en) * | 1992-03-02 | 1993-09-16 | Alcon Laboratories, Inc. | Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions |
| CA2133966C (en) * | 1992-04-21 | 1997-09-09 | David A. Sullivan | Ocular androgen therapy in sjogren's syndrome |
| US5505953A (en) * | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| CA2132826C (en) * | 1992-05-06 | 1999-01-05 | Masood Chowhan | Use of borate-polyol complexes in ophthalmic compositions |
| JPH06153607A (ja) * | 1992-11-30 | 1994-06-03 | Kinsaku Kida | 農耕用作業車と農耕作業部との連結装置 |
| CA2134376C (en) * | 1993-12-20 | 2001-10-23 | Haresh G. Bhagat | Combinations of polymers for use in physiological tear compositions |
| WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
| EP0984782A2 (de) * | 1997-06-04 | 2000-03-15 | Akzo Nobel N.V. | Verwendung von entzündungshemmenden steroiden zur behandlung von chronischen entzündlichen darmerkrankungen |
| CA2379605C (en) * | 1999-09-24 | 2007-06-26 | Alcon, Inc. | Topical suspension formulations containing ciprofloxacin and dexamethasone |
-
2003
- 2003-12-15 UY UY28126A patent/UY28126A1/es not_active Application Discontinuation
- 2003-12-15 TW TW092135379A patent/TWI335819B/zh not_active IP Right Cessation
- 2003-12-18 ES ES03799978T patent/ES2316867T3/es not_active Expired - Lifetime
- 2003-12-18 DE DE60325770T patent/DE60325770D1/de not_active Expired - Lifetime
- 2003-12-18 KR KR1020057011855A patent/KR100889170B1/ko not_active IP Right Cessation
- 2003-12-18 JP JP2004563765A patent/JP2006513213A/ja active Pending
- 2003-12-18 PT PT03799978T patent/PT1575597E/pt unknown
- 2003-12-18 AT AT03799978T patent/ATE419856T1/de active
- 2003-12-18 SI SI200331489T patent/SI1575597T1/sl unknown
- 2003-12-18 AU AU2003299696A patent/AU2003299696B2/en not_active Ceased
- 2003-12-18 MX MXPA05006985A patent/MXPA05006985A/es active IP Right Grant
- 2003-12-18 KR KR1020097001470A patent/KR20090018222A/ko not_active Application Discontinuation
- 2003-12-18 CA CA002507375A patent/CA2507375C/en not_active Expired - Fee Related
- 2003-12-18 RU RU2005123388/14A patent/RU2330668C2/ru not_active IP Right Cessation
- 2003-12-18 PL PL378877A patent/PL378877A1/pl not_active Application Discontinuation
- 2003-12-18 US US10/739,824 patent/US20040132704A1/en not_active Abandoned
- 2003-12-18 WO PCT/US2003/040374 patent/WO2004058273A1/en active Application Filing
- 2003-12-18 DK DK03799978T patent/DK1575597T3/da active
- 2003-12-18 BR BR0317774-2A patent/BR0317774A/pt not_active IP Right Cessation
- 2003-12-18 CN CNB200380107558XA patent/CN100388919C/zh not_active Expired - Fee Related
- 2003-12-18 EP EP03799978A patent/EP1575597B1/de not_active Expired - Lifetime
- 2003-12-18 ZA ZA200503975A patent/ZA200503975B/en unknown
- 2003-12-22 AR ARP030104778A patent/AR042790A1/es unknown
-
2005
- 2005-09-28 HK HK05108569.9A patent/HK1076248A1/xx not_active IP Right Cessation
- 2005-10-14 US US11/250,262 patent/US20060058277A1/en not_active Abandoned
-
2007
- 2007-10-26 US US11/925,178 patent/US20080096852A1/en not_active Abandoned
-
2009
- 2009-03-10 CY CY20091100271T patent/CY1108862T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100889170B1 (ko) | 2009-03-16 |
| KR20090018222A (ko) | 2009-02-19 |
| CA2507375C (en) | 2009-11-24 |
| US20080096852A1 (en) | 2008-04-24 |
| AU2003299696A1 (en) | 2004-07-22 |
| US20040132704A1 (en) | 2004-07-08 |
| CN1732008A (zh) | 2006-02-08 |
| CA2507375A1 (en) | 2004-07-15 |
| MXPA05006985A (es) | 2005-08-16 |
| AU2003299696B2 (en) | 2009-08-13 |
| RU2330668C2 (ru) | 2008-08-10 |
| KR20050086937A (ko) | 2005-08-30 |
| EP1575597A1 (de) | 2005-09-21 |
| UY28126A1 (es) | 2004-06-30 |
| CN100388919C (zh) | 2008-05-21 |
| ZA200503975B (en) | 2006-12-27 |
| EP1575597B1 (de) | 2009-01-07 |
| ES2316867T3 (es) | 2009-04-16 |
| BR0317774A (pt) | 2005-11-22 |
| TWI335819B (en) | 2011-01-11 |
| HK1076248A1 (en) | 2006-01-13 |
| SI1575597T1 (sl) | 2009-04-30 |
| TW200418492A (en) | 2004-10-01 |
| AR042790A1 (es) | 2005-07-06 |
| US20060058277A1 (en) | 2006-03-16 |
| CY1108862T1 (el) | 2014-07-02 |
| PL378877A1 (pl) | 2006-05-29 |
| JP2006513213A (ja) | 2006-04-20 |
| RU2005123388A (ru) | 2006-01-20 |
| ATE419856T1 (de) | 2009-01-15 |
| PT1575597E (pt) | 2009-02-02 |
| DK1575597T3 (da) | 2009-03-16 |
| WO2004058273A1 (en) | 2004-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325770D1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| ATE357440T1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| DE50014041D1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| ATE423099T1 (de) | Zur behandlung von schmerzen geeignete piperazine | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
| DE60223707D1 (de) | Calcium-l-threonat zur behandlung von knochenfrakturen | |
| DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| DE60325496D1 (de) | Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| DE50308460D1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen | |
| DE69934336D1 (de) | Verwendung von halofuginone zur behandlung von urethralstriktur | |
| ATE359270T1 (de) | Phenyl-piperidin-4-yliden-methyl-benzamidderiva e zur behandlung von schmerz oder magen-darm- erkrankungen | |
| DE602004026830D1 (de) | Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |